Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?
about
Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients.Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns studyEffect of colestilan on serum phosphorus in dialysis patients: A meta-analysis of the literature.Usefulness and feasibility of measuring ionized calcium in haemodialysis patients.Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in BeijingClinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines.Bone mineral metabolism and subsequent hospitalization with poor quality of life in dialysis patientsA Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?The role of phosphate in kidney disease.Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial.Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical Trials.Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study.CKD-MBD KDIGO guidelines: how difficult is reaching the 'target'?Compliance with mineral metabolism targets in haemodialysis patients: moving backwards?Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort.
P2860
Q33625482-22F4EA07-7B2C-4786-8EB2-065138E83FA2Q35648040-712591B2-5958-4622-A449-A4F66E8A9083Q35745578-652BF365-BA0E-48A2-B51A-D257CCFBB164Q35891563-0DD8D60D-E7CF-4FAE-8ECA-E80C0E3D5B7AQ36238088-DE7B00AB-02F1-4789-91A7-12D469F0A278Q36432849-394161CF-211F-4A5C-8E31-9A3EEF160796Q37492301-CCC4F68B-2A85-4AC6-A21C-7E2149D4513AQ37671125-78DC0A67-D54B-44CB-94C6-5CDF914CDEAFQ38741675-59B550F1-3A4B-4B6F-8012-E11102CD771CQ38793054-9632730E-6248-46C4-AB98-5CE50B1C26B3Q40505616-8E36EAE1-B3B7-48C0-AE89-3E2028BCD949Q47571217-938B4719-9363-4A7D-8778-136F2B58B014Q48283940-EAF6532B-1D97-48AC-9D2C-94EE0ED7827DQ49433201-F53B1682-0003-4BE6-9E68-8BC78C04FE26Q50022061-C8EDE03E-FFBD-4491-B748-23E35D445BA8Q53780644-1A2852B5-5ABD-43E9-83B4-5616A89CCA85Q55436115-8561E8FE-432D-43AF-B397-5EBD48821698
P2860
Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Control of mineral metabolism ...... tients: which optimal targets?
@en
Control of mineral metabolism ...... tients: which optimal targets?
@nl
type
label
Control of mineral metabolism ...... tients: which optimal targets?
@en
Control of mineral metabolism ...... tients: which optimal targets?
@nl
prefLabel
Control of mineral metabolism ...... tients: which optimal targets?
@en
Control of mineral metabolism ...... tients: which optimal targets?
@nl
P2093
P2860
P356
P1476
Control of mineral metabolism ...... tients: which optimal targets?
@en
P2093
Guillaume Jean
Gérard M London
Hubert Roth
Jean-Louis Bouchet
Solenne Pelletier
Thierry Hannedouche
P2860
P304
P356
10.1093/NDT/GFS404
P407
P577
2012-11-06T00:00:00Z